BIOFLORIN caps bte 25 pce

7680405060125 CH-40506 A07FA01 04.09.0.
BIOFLORIN caps bte 25 pce
BIOFLORIN caps bte 25 pce
BIOFLORIN caps bte 25 pce
1 / 3
google

Details

Product number
4050601
CPT
-
Packaging group
25
Unit
Kapsel(n)
Composition
enterococcus faecium vivus (typus SF 68) 75 Mio CFU, lactosum monohydricum 253.70 mg, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, Drucktinte: E 172 (nigrum), pro capsula.

Articles (1)

Bioflorin, Kapseln
Kapseln
25
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/07/2025
Patient information leaflet
Français
05/07/2025
Patient information leaflet
Italien
05/07/2025
Professional SmPC
Allemand
05/07/2025
Professional SmPC
Français
05/07/2025
Professional SmPC
Italien
05/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
253.7 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Authorization holder

Opella Healthcare Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
40506
Drug name
Bioflorin, Kapseln
Galenic form
KAHA
ATC Code
A07FA01
Authorization status
Z
Dispensation category
D
First authorization
15/01/1979
Authorization expiration date
31/12/9999
IT number
04.09.0.
Domain
Human medicine
Field of application
Wiederherstellung der Darmflora, Antidiarrhoikum

Packaging details

Description (FR)
BIOFLORIN caps bte 25 pce
Description (DE)
BIOFLORIN Kaps Ds 25 Stk
Market launch
15/01/1979
Narcotic (BTM)
No

Application methods

ORA

Other packaging sizes

BIOFLORIN caps bte 50 pce
2x25 KAP
View